News & Updates

Show Multimedia Only

Abrocitinib safe, effective in moderate-to-severe atopic dermatitis after dupilumab use

26 Jul 2022 by

Treatment with abrocitinib is both safe and effective in patients with moderate-to-severe atopic dermatitis (AD), regardless of prior dupilumab response status, a study has shown.

26 Jul 2022

$Weekly hypofractionated radiotherapy safe, effective in elderly cSCC patients$

Weekly hypofractionated radiotherapy safe, effective in elderly cSCC patients

26 Jul 2022

A weekly treatment schedule of hypofractionated radiotherapy appears to yield good response rate in elderly patients with cutaneous squamous cell carcinoma (cSCC), while having minimal side effects, a study has shown.

26 Jul 2022

Atopic eczema tied to higher risk of dementia in older adults

25 Jul 2022 by

Having an atopic eczema appears to slightly increase one’s risk of incident dementia, particularly among older adults, suggests a study. Such risk further grows with the severity of atopic eczema.

25 Jul 2022

3 clusters define outcome profiles in bullous pemphigoid

25 Jul 2022

A recent study has identified three different clusters of bullous pemphigoid (BP), which includes one corresponding to severe BP180+ BP230− with features common to mucous membrane pemphigoid.

25 Jul 2022

Poor lifestyle ups risk of incident psoriasis

24 Jul 2022

Poor lifestyle appears to increase the risk of incident psoriasis irrespective of genetic risk, suggest the results of a recent study. Additionally, lifestyle factors have a greater relative impact than genetic risk.

24 Jul 2022

Smoking, discoid lesions prevent long-term remission in cutaneous lupus erythematosus

23 Jul 2022

Very few patients with cutaneous lupus erythematosus (CLE) achieve long-term remission, which is negatively associated with active smoking and discoid CLE, reports a study.

23 Jul 2022

Ribociclib–binimetinib combo safe, effective in NRAS-mutant melanoma

22 Jul 2022

Treatment with the combination of ribociclib plus binimetinib appears to be well tolerated and delivers modest clinical activity in patients with locally advanced or metastatic melanoma harbouring NRAS mutation, according to the results of a phase Ib/II study.

22 Jul 2022

Investigational nitric oxide gel for water warts scores high in phase III trial

21 Jul 2022 by

A novel nitric oxide-releasing gel, berdazimer 10.3%, proves effective in the treatment of patients with water warts or molluscum contagiosum skin infection, facilitating clearance of lesions with low adverse event rates, as shown in the phase III B-SIMPLE4 trial.

21 Jul 2022

An aspirin a day does not keep melanoma at bay

13 Jul 2022

Taking aspirin daily appears to do nothing in terms of reducing the risk of cutaneous melanoma in older individuals, according to a study.

13 Jul 2022

Monkeypox: Why the sudden concern?

11 Jul 2022 by

Just as the world adapts to a new normal after the COVID-19 pandemic, a new outbreak of a not-so-new virus has been making headlines. But why the sudden concern?

11 Jul 2022

News & Updates

Showing Dermatology articles

Showing

Specialty:

Abrocitinib safe, effective in moderate-to-severe atopic dermatitis after dupilumab use

Weekly hypofractionated radiotherapy safe, effective in elderly cSCC patients

Atopic eczema tied to higher risk of dementia in older adults

3 clusters define outcome profiles in bullous pemphigoid

Poor lifestyle ups risk of incident psoriasis

Smoking, discoid lesions prevent long-term remission in cutaneous lupus erythematosus

Ribociclib–binimetinib combo safe, effective in NRAS-mutant melanoma

Investigational nitric oxide gel for water warts scores high in phase III trial

An aspirin a day does not keep melanoma at bay

Monkeypox: Why the sudden concern?